6th Metabolism-based Cancer Therapy Symposium 2026

Monday, November 30, 2026 ・ONLINE

Welcome to the 6th Metabolism-based Cancer Therapy Symposium

On November 30, 2026, leading international scientists and clinicians will come together online to discuss current advances in cancer metabolism and their translation into therapeutic strategies.

The program will explore metabolic vulnerabilities, immunometabolism, tumor adaptation, mutation-driven metabolic dependencies and the clinical development of metabolism-based cancer therapies.

We look forward to an inspiring scientific exchange across disciplines and to discussing how emerging insights in cancer metabolism can inform future translational and clinical approaches.

Organizing Team

Dr. med. Ekaterina Balaian, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. med. Martin Bornhäuser, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. med. Triantafyllos Chavakis, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Dr. Mohamed Elgendy, PhD, Institute of Pharmacology and Toxicology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. Leoni Kunz-Schughart, OncoRay - National Center of Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Visual impressions from the MBCT Symposium 2025

Following the positive response in 2025, the MBCT Symposium will once again feature graphic recording in 2026. Key ideas, insights and discussions from the event will be captured visually and made available to all participants afterwards—providing a valuable and lasting resource to revisit and share.

Session 1 - 2

All times are given in Central European Time, CET (UTC+1)

13:15–13:25 CET
Welcome and Opening Remarks
Ekaterina Balaian, Dresden, Germany
Mohamed Elgendy, Dresden, Germany

SESSION 1: Metabolism-Based Cancer Therapies
Chairs: Mohamed Elgendy and Ekaterina Balaian

13:25–13:45 CET
Nature Metabolism Editors’ Perspective: Emerging Topics and Future Directions in Cancer Metabolism
Editor invited

13:55–14:15 CET
From Tumor Metabolism to Precision Oncology: Clinical Experience with MTA-Cooperative PRMT5 Inhibition
Paul Bröckelmann, Cologne, Germany

SESSION 2: Immunometabolism and Metabolic Adaptation in the Tumor Microenvironment
Chairs: Martin Bornhäuser and Triantafyllos Chavakis

14:25–14:45 CET
Immunogenic Cell Death in the Tumor Microenvironment
Pascal Meier, Institute of Cancer Research, London, UK, invited

14:55–15:15 CET
Immunometabolism, T Cells and the Tumor Microenvironment
Naomi Taylor, Bethesda, USA

15:25–15:45 CET
Postprandial Lipid Metabolism and T Cell Immunity
Greg Delgoffe, Pittsburgh, USA, invited


Break 15:55–16:10 CET

Session 3 - 4

All times are given in Central European Time, CET (UTC+1).

SESSION 3: Mutation-Based Metabolic Vulnerabilities and Therapies
Chairs: Ekaterina Balaian and Leoni Kunz-Schughart

16:10–16:30 CET
Patient Perspective
Matthias Weigel, Dresden, Germany, invited

16:40–17:00 CET
SDH Deficiency and Metabolism: Insights from a Patient Cohort and Gaps in the Field
Hussam Alkaissi, Bethesda, USA

17:10–17:30 CET
Technical Approaches to Metabolic Imaging
N.N.

17:40–18:00 CET
Biological Basis and Clinical Development of IDH1 Inhibitors and Novel Compounds
Michael Heuser, Halle (Saale), Germany

SESSION 4: Translating Cancer Metabolism into the Clinic
Chair: Leoni Kunz-Schughart

18:10–18:35 CET
Translating Cancer Metabolism into the Clinic: Biological Complexity, Therapeutic Challenges and Future Opportunities
Douglas Hanahan, Lausanne, Switzerland, invited

18:40–18:45 CET
Closing Remarks
Leoni Kunz-Schughart, Dresden, Germany

Max. participants: 250
Registrations: 7

Registration

Fields marked with an asterisk (*) are mandatory and must be filled in.


(Show data privacy declaration)

Scientific administration

Dr. med. Ekaterina Balaian, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Prof. Martin Bornhäuser, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Dr. Mohamed Elgendy, Institute of Pharmacology and Toxicology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Prof. Dr. Leoni Kunz-Schughart, OncoRay - National Center of Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Prof. Dr. med. Triantafyllos Chavakis, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

 

Organizer

GWT-TUD GmbH
Freiberger Straße 33
01067 Dresden

Conference time

Monday, November 30, 2026 · ONLINE
13:15–18:15 CET (UTC+1)

Broadcast

via Zoom

Continuing Medical Education Credits (CME)

The CME credits have now been confirmed by the Saxon State Medical Association. The event has been granted 5 continuing medical education points.

Felix Manthei
Project Manager

Mobile: +49 163 250 72 07
Phone: +49 351 25 933 210

GWT-TUD GmbH
Freiberger Straße 33
01067 Dresden
Germany

Metabolism-based Cancer Therapy Symposium 2025

18th November 2025, online

Metabolism-based Cancer Therapy Symposium 2024

26th November 2024, online

Metabolism-based Cancer Therapy Symposium 2023

30th November 2023, online

Metabolism-based Cancer Therapy Symposium 2022

30th November 2022, online

Metabolism-based Cancer Therapy Symposium 2021

8th October 2021, Dresden

Photo credit: Graphic elements designed by Freepik